The Corporate Liaison Board Hosts 9th Annual Forum at ENDO 08

The 2008 CLB Program “Pathways in the Control of Metabolism: Emerging Links” was extremely successful, with over 340 attendees. 94% of attendees reported that they would recommend the program to their colleagues and 88% of attendees rated the speakers’ delivery, knowledge and organization of the presentation as above average or excellent. 

Comments from attendees ranged from, “Bone talk was very, very good. Great discussion” to “This was an intellectually exciting program”.

Don’t miss another great program in 2009! The topic for the 2009 CLB Forum is: “Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development” 

• How to bring an innovative assay to market 
• Controversies in the Use of Biomarkers as Surrogate Endpoints in Endocrine Trials 
• Application of Existing Cardiometabolic Biomarkers in Clinical Trials 

To learn more about the 2009 CLB Forum, please visit the ENDO 09 Web site. Registration will be open in December 2008. There is no cost to attend this event, but seating reservations are on a first-come, first-served basis. 

In order to receive more information, please contact Nancy Chill at nchill@endo-society.org or 301-941-0203.

We look forward to seeing you in DC.